These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis. Appel H; Mertz A; Distler A; Sieper J; Braun J J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678 [TBL] [Abstract][Full Text] [Related]
44. Characterization of circulating Yersinia-specific immune complexes in patients with yersiniosis. Lahesmaa-Rantala R; Granfors K; Lehtonen OP; Toivanen A Clin Immunol Immunopathol; 1987 Feb; 42(2):202-10. PubMed ID: 2948750 [TBL] [Abstract][Full Text] [Related]
45. Prevalence of antibodies to human serogroups of Yersinia enterocolitica in blood donors in Nigeria. Agbonlahor DE; Odugbemi TO; Dosunmu-Ogunbi O Cent Afr J Med; 1986 Sep; 32(9):217-20. PubMed ID: 3652191 [No Abstract] [Full Text] [Related]
47. The serodiagnosis of human infections with Yersinia enterocolitica and Yersinia pseudotuberculosis. Chart H; Cheasty T FEMS Immunol Med Microbiol; 2006 Aug; 47(3):391-7. PubMed ID: 16872375 [TBL] [Abstract][Full Text] [Related]
48. [Application of released proteins (RPs) of Yersinia Enterocolitica for serological diagnosis of yersiniosis. I. Antigen for ELISA]. Rastawicki W; Jagielski M; Gierczyński R Med Dosw Mikrobiol; 2003; 55(2):125-33. PubMed ID: 14577192 [TBL] [Abstract][Full Text] [Related]
49. [Prevalence of antibodies to Yersinia enterocolitica 0:3 0:9 in an Italian agricultural area]. Pugina P; Fantasia-Mazzotti M; Giraldi V; Benzi G; Nocera F; Mingrone MG Nuovi Ann Ig Microbiol; 1984; 35(4):269-76. PubMed ID: 6544399 [No Abstract] [Full Text] [Related]
50. Yersinia enterocolitica antibodies in thyroid disorders. Weiss M; Rubinstein E; Bottone EJ; Shenkman L; Bank H Isr J Med Sci; 1979 Jul; 15(7):553-5. PubMed ID: 478816 [TBL] [Abstract][Full Text] [Related]
51. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice. Vogel U; Autenrieth IB; Berner R; Heesemann J Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625 [TBL] [Abstract][Full Text] [Related]
52. [Humoral response to recombinant YeuB, Ail, YadA and Inv proteins of Yersinia enterocolitica in patients with yersiniosis]. Rastawicki W Med Dosw Mikrobiol; 2009; 61(1):21-32. PubMed ID: 19517812 [TBL] [Abstract][Full Text] [Related]
53. Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients. Cherchi GB; Cossellu S; Pacifico L; Gallisai D; Ranucci A; Zanetti S; Fadda G; Chiesa C Contrib Microbiol Immunol; 1995; 13():16-8. PubMed ID: 8833786 [No Abstract] [Full Text] [Related]
54. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878 [TBL] [Abstract][Full Text] [Related]
55. [Assay of anti-Yersinia enterocolitica antibodies in an open population sample of the town of Messina]. Delia SA; Crupi D; Zaccone R Ann Sclavo; 1982; 24(4):429-39. PubMed ID: 7187210 [No Abstract] [Full Text] [Related]
57. Antibodies against cell envelope antigens of Yersinia enterocolitica in reactive arthritis and ankylosing spondylitis. van Bohemen CG; van Alphen AJ; Zanen-Lim OG; Dekker-Saeys AJ; Zanen HC Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):83-4. PubMed ID: 6652395 [TBL] [Abstract][Full Text] [Related]
58. Natural course of a raised Yersinia enterocolitica antibody titre in an unselected, adult population followed during one year. Agner E Dan Med Bull; 1983 May; 30(3):200-3. PubMed ID: 6861532 [No Abstract] [Full Text] [Related]
59. [Yersinia enterocolitica infections and their most frequent complications]. Larsen JH Ugeskr Laeger; 1977 Oct; 139(44):2627-32. PubMed ID: 929741 [No Abstract] [Full Text] [Related]
60. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously]. Ferrara M; Galdo Capotorti M; Ponte G; Esposito L Pediatria (Napoli); 1983; 91(4):371-7. PubMed ID: 6545400 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]